Evidence map›Paper›PMID 31861362›Full record

ReviewFoods (Basel, Switzerland)2019

A Review of Factors Affecting Anthocyanin Bioavailability: Possible Implications for the Inter-Individual Variability.

Merve Eda Eker, Kjersti Aaby, Irena Budic-Leto, Suzana Rimac Brnčić, Sedef Nehir El, Sibel Karakaya, Sebnem Simsek, Claudine Manach, Wieslaw Wiczkowski, Sonia de Pascual-Teresa

Open access · goldAbstract readReview
In one paragraph

Review in Foods (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 4 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 4 syntheses or guidelines pooled it, 207 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 6 countries.

Merve Eda EkerDepartment of Metabolism and Nutrition, Institute of Food Science, Technology and Nutrition (ICTAN-CSIC), Jose Antonio Novais 10, 28040 Madrid, Spain.
Kjersti AabyNofima, Norwegian Institute of Food, Fisheries and Aquaculture Research, N-1430 Ås, Norway.
Irena Budic-LetoInstitute for Adriatic Crops and Karst Reclamation, Put Duilova 11, 21000 Split, Croatia.
Suzana Rimac BrnčićFaculty of food Technology and Biotechnology, University of Zagreb, Pierottijeva 6, 10000 Zagreb, Croatia.
Sedef Nehir ElDepartment of Food Engineering, Ege University, 35100 Izmir, Turkey.
Sibel KarakayaDepartment of Food Engineering, Ege University, 35100 Izmir, Turkey.
Sebnem SimsekDepartment of Food Engineering, Ege University, 35100 Izmir, Turkey.
Claudine ManachINRA, Université Clermont-Auvergne, Human Nutrition Unit, CRNH Auvergne, F-63000 Clermont-Ferrand, France.
Wieslaw WiczkowskiInstitute of Animal Reproduction and Food Research. Polish Academy of Sciences, 10-748 Olsztyn, Poland.
Sonia de Pascual-TeresaDepartment of Metabolism and Nutrition, Institute of Food Science, Technology and Nutrition (ICTAN-CSIC), Jose Antonio Novais 10, 28040 Madrid, Spain.
Ege University · TRConsejo Superior de Investigaciones Científicas · ESInLife Institute of Animal Reproduction and Food Research, Polish Academy of Sciences · PLInstitute for Adriatic Crops and Karst Reclamation · HRNofima · NOUniversité Clermont Auvergne · FRUniversity of Zagreb · HR

Funding

EXPANSION OF HUMAN STEM CELLS WITH TRANSPLANTATION MODELR44CA076832 · NCI · QUALITY BIOLOGICAL, INC. · PI BROWN, RONALD L · 1997 to 1999
–
European Cooperation in Science and Technology FA1403 POSITIVeMinisterio de Ciencia, Innovación y Universidades AGL2016-76832-R
6 · The paper itself

Abstract

Anthocyanins are dietary bioactive compounds showing a range of beneficial effects against cardiovascular, neurological, and eye conditions. However, there is, as for other bioactive compounds in food, a high inter and intra-individual variation in the response to anthocyanin intake that in many cases leads to contradictory results in human trials. This variability could be caused at two levels, one at the bioavailability level and the other at the effect and mechanisms of action. In this context, we have thoroughly reviewed the scientific literature on anthocyanins variability caused by variation in bioavailability. Based on the literature reviewed, we have concluded that the variability in anthocyanins bioavailability might be produced by the lack of homogeneity introduced at three different levels: food matrix and food processing, enzymes involved in anthocyanin metabolism and transport, and anthocyanin metabolizing gut microbiota. However, it should be noted that the literature on anthocyanins bioavailability considering inter or intra-individual variability is still very scarce, which makes it difficult to reach any firm conclusion on the main metabolizing enzymes or bacteria that would be responsible for the variability in anthocyanin bioavailability.

Indexed as

anthocyaninbioavailabilityfood processingmetabolismmicrobiotavariability

Identifiers

PMID31861362
PMCPMC7023094
OpenAlexW2996374637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.